Boston Scientific Corp. said Friday it is recalling 200 of its recently approved drug-eluting coronary stents because of a malfunction that has been blamed for at least one death. The ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/52041d/the_top_60_manufac) has announced the addition of the "The Top 60 ...

Rockville MD - Cordis/Johnson & Johnson has responded to an eight-page FDA letter detailing problems with stent manufacturing practices by insisting that it will be rectifying "all identified issues ...

The govt added coronary stents to the national list of essential medicines 2015, bringing them under price control, a move opposed by stent manufacturers Exciting, sharp and clear analysis of the ...

As a final result of the Russia-Ukraine warfare and COVID-19, the world financial system will recover, and the world “Vascular Stent Market” dimension will extend to USD million in 2022 from USD ...

WASHINGTONWASHINGTON — Shares of medical device maker ev3 Inc. jumped Friday after results from a new study suggested stents could be used to prevent stroke in hundreds of thousands of new patients.

Industry sources suggest the pricing change was prompted by the recent Khyati hospital controversy. Prior to this change, all stents were reimbursed at approximately Rs 34,000 regardless of approval ...

The winter of 2006 was a period that cardiac stent manufacturers would rather forget. Negative studies out of Europe reported on the dangers of late stent thrombosis (LST) in patients with drug ...

They want to manufacture coronary and peripheral bare-metal and drug-eluting stents and offer them to Iranian hospitals at a more affordable price. The firm is looking to buy stent technology and the ...

New York, NY - In one side's telling, the rivalry pitting Boston Scientific's Taxus TM drug-eluting stent against Johnson & Johnson's Cypher TM can be traced back to a dinner date in 1995, when J&J ...

Boston Scientific has recalled carotid artery stents because of a manufacturing defect that has led to additional interventions to recover the devices. The Food and Drug Administration, which shared ...